Evaluation of anti tumour activity of ethanolic extract of beet root (Beta vulgaris) against EAC mouse tumor model

P. Sravan Kumar, Asish Bhaumik, Domandula Babu Rao, Monica Chopra

Abstract


Introduction: EAC is referred to as undifferentiated carcinoma, and is originally hyper-diploid. The permeability to water is highest at the initiation of S and progressively decreases to its lowest value just after mitosis. Activation heats for water permeability vary during the cell cycle, ranging from 914 k. ca/mole.

Methodology: The extraction of phytoconstituents was carried out by reflux condensation and preliminary phytochemical screening was done by various qualitative confirmatory tests. The in vivo anti tumour activity of ethanolic extract of beet root (EEBT) was carried out on EAC mouse tumour models.

Results: All five animals were in both 5-FU as well as EEBT group. So mortality was less in both 5-FU and EEBT group. The Hb and RBC count were lower in tumour control group. The WBC counts were significantly increased in tumour control. 5-FU and EEBT mg/kg group decreased the WBC counts approximately near to normal range. The neutrophils were increased and lymphocytes were decreased significantly in tumour control group. The platelet count was also significantly increased in tumour control and EEBT (200 mg/kg) group compared nearly to normal group. EEBT and 5-FU significantly increased the PILS. While 5-FU increased the life span of EAC 90.90% and EEBT increased the life span of EAC 86.36%.

Conclusion: From the present experimental data here we concluded that the EEBT possessed potential anti tumour activity against EAC mouse tumour model which was proved by the assessment of haematological parameters as well as by Percent increase of lifespan (% ILS). The Percent increase of lifespan ( PILS) of both standard group as well as EEBT treated group was found to be 90.90% and 86.36%.


Keywords


EAC, carcinoma, anti tumour activity, PILS

Full Text:

PDF


DOI: https://doi.org/10.7439/ijpr.v7i3.3943



Copyright (c) 2017 International Journal of Pharmacological Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.